Pain：外科可有效预防偏头痛复发和加重

美联社从日前在京召开的2011年诊疗的国际研讨会上获悉，首都医科大学附属北京中医医院诊疗的中心经诊疗深入研究推测，传统文化的中医诊疗疗法可理论上持续性病症的复发和加重。无关深入研究深入研究成果据悉公开发表在的国际著名医学期刊《呕吐》上，被选为中国大陆首篇公开发表于该杂志的诊疗深入研究深入研究成果。该文还被的国际著名医学生物科学机构 Faculty of 1000 medicine（千名医学家）翻唱。

据了解，作为诊疗常见病之一，病症出生率更高，且危害情况严重。目前，我国18岁~65岁人群的病症患病率更超过9.3%，且有逐年升更高趋势。诊疗病人头痛在中国已经有数千年的历史。北京中医医院诊疗的中心自2004年另设头痛专家门诊，开展了基于“木棉中山王板桥乡”、国医大师贺普仁等多位著名诊疗学家治痛潜能的头痛深入研究。

据该的中心主任中山王麟鹏参考，该项目实行单盲、双模拟、系统性的表达方式，在国内5家医院的诊疗科共应征140名无先兆病症患者，随机划分两四组，分别为病人四组（诊疗加安慰剂）和对照四组（假针加氟桂利嗪）。两四组患者每周诊疗病人3次，每晚口服药物。结果显示，4都于，病人四组病症的理论上消除率为59%，对照四组为40%；病人四组呕吐时间段平均回升4.1天，对照四组平均回升1.9天。16都于，病人四组理论上消除率为56%，对照四组为37%；病人四组呕吐时间段平均回升 4.1天，对照四组平均回升2天。

深入研究医护人员据此认为，诊疗可以作为病症的持续性复发和加重的分析方法，其治果也优于此前国外的无关深入研究。由于其深入研究分析方法的新颖和层面，该深入研究成果还被的国际著名医学生物科学机构“千名研究小组”翻唱。（生物谷 Bioon.com）

doi:10.1016/j.pain.2011.04.006PMC:PMID:

Efficacy of acupuncture for migraine prophylaxis: A single-blinded, double-dummy, randomized controlled trial

Lin-Peng Wang,Xiao-Zhe Zhang,Jia Guo,Hui-Lin Liu,Yan Zhang,Cun-Zhi Liu,Jing-Hong Yi,Li-Ping Wang,Ji-Ping Zhao,Shan-Shan Li

Summary This multicenter, double-dummy trial suggested that acupuncture was more effective than flunarizine in decreasing days of migraine attacks. Abstract Insufficient clinical trial data were ailable to prove the efficacy of acupuncture for migraine prophylaxis. A multicenter, double-dummy, single-blinded, randomized controlled clinical trial was conducted at the outpatient departments of acupuncture at 5 hospitals in China to evaluate the effectiveness of acupuncture. A total of 140 patients with migraine without aura were recruited and assigned randomly to 2 different groups: the acupuncture group treated with verum acupuncture plus placebo and the control group treated with sham acupuncture plus flunarizine. Treated by acupuncture 3 times per week and drugs every night, patients from both groups were evaluated at week 0 (baseline), week 4, and week 16. The primary outcome was measured by the proportion of responders (defined as the proportion of patients with a reduction of migraine days by at least 50%). The secondary outcome measures included the number of migraine days, visual ogue scale (VAS, 0 to 10cm) for pain, as well as the physical and mental component summary scores of the 36-item short-form health survey (SF-36). The patients in the acupuncture group had better responder rates and fewer migraine days compared with the control group (P.05). The results suggested that acupuncture was more effective than flunarizine in decreasing days of migraine attacks, whereas no significantly differences were found between acupuncture and flunarizine in reduction of pain intensity and improvement of the quality of life.